Persons with dispensed medicines; background; 2006-2020
Sex | Age | Background and generation | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
---|---|---|---|---|---|
Total male and female | Total age | (former) Net Antilles, Aruba | A02 Drugs for acid related disorders | 2020 | 7.04 |
Total male and female | Total age | (former) Net Antilles, Aruba | A02B Drugs for peptic ulcer and gord | 2020 | 7.04 |
Total male and female | Total age | (former) Net Antilles, Aruba | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | A03 Drugs for funct.gastrointest.disord. | 2020 | 1.81 |
Total male and female | Total age | (former) Net Antilles, Aruba | A03A Drugs for functional bowel disord. | 2020 | 0.43 |
Total male and female | Total age | (former) Net Antilles, Aruba | A14 Anabolic agents for systemic use | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | B Blood and blood forming organs | 2020 | 7.62 |
Total male and female | Total age | (former) Net Antilles, Aruba | D01 Antifungals for dermatological use | 2020 | 5.01 |
Total male and female | Total age | (former) Net Antilles, Aruba | D01A Antifungals for topical use | 2020 | 4.69 |
Total male and female | Total age | (former) Net Antilles, Aruba | D01B Antifungals for systemic use | 2020 | 0.47 |
Total male and female | Total age | (former) Net Antilles, Aruba | D03 Means for wounds & ulcers treatment | 2020 | 0.01 |
Total male and female | Total age | (former) Net Antilles, Aruba | D05A Antipsoriatics for topical use | 2020 | 0.30 |
Total male and female | Total age | (former) Net Antilles, Aruba | D05B Antipsoriatics for systemic use | 2020 | 0.03 |
Total male and female | Total age | (former) Net Antilles, Aruba | D06 Antibiotics.. for dermatological use | 2020 | 3.23 |
Total male and female | Total age | (former) Net Antilles, Aruba | D06A Antibiotics for topical use | 2020 | 2.62 |
Total male and female | Total age | (former) Net Antilles, Aruba | D06B Chemotherapeutics for topical use | 2020 | 0.66 |
Total male and female | Total age | (former) Net Antilles, Aruba | G02B Contraceptives for topical use | 2020 | 0.10 |
Total male and female | Total age | (former) Net Antilles, Aruba | H02 Corticosteroids for systemic use | 2020 | 2.83 |
Total male and female | Total age | (former) Net Antilles, Aruba | J General antiinfectives for system.use | 2020 | 15.72 |
Total male and female | Total age | (former) Net Antilles, Aruba | J01 Antibacterials for systemic use | 2020 | 14.11 |
Total male and female | Total age | (former) Net Antilles, Aruba | J02 Antimycotics for systemic use | 2020 | 1.02 |
Total male and female | Total age | (former) Net Antilles, Aruba | J02A Antimycotics for systemic use | 2020 | 1.02 |
Total male and female | Total age | (former) Net Antilles, Aruba | J04A Drugs for treatment of tuberculosis | 2020 | 0.05 |
Total male and female | Total age | (former) Net Antilles, Aruba | J04B Drugs for treatment of lepra | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | J05 Antivirals for systemic use | 2020 | 0.99 |
Total male and female | Total age | (former) Net Antilles, Aruba | M05 Drugs for treatment of bone diseases | 2020 | 0.37 |
Total male and female | Total age | (former) Net Antilles, Aruba | M09 Oth.drugs for musculo-skelet.disord. | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | R03 Drugs for obstruct. airway diseases | 2020 | 7.86 |
Total male and female | Total age | (former) Net Antilles, Aruba | R03C Adrenergics for systemic use | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | R06 Antihistamines for systemic use | 2020 | 9.88 |
Total male and female | Total age | (former) Net Antilles, Aruba | R06A Antihistamines for systemic use | 2020 | 9.88 |
Total male and female | Total age | (former) Net Antilles, Aruba | V06A Obesity treatment diet formulations | 2020 | 0.00 |
Total male and female | Total age | (former) Net Antilles, Aruba | V06C Infant formulas | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A02 Drugs for acid related disorders | 2020 | 0.32 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A02B Drugs for peptic ulcer and gord | 2020 | 0.32 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A03 Drugs for funct.gastrointest.disord. | 2020 | 0.15 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A03A Drugs for functional bowel disord. | 2020 | 0.03 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | A14 Anabolic agents for systemic use | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | B Blood and blood forming organs | 2020 | 0.72 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D01 Antifungals for dermatological use | 2020 | 4.23 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D01A Antifungals for topical use | 2020 | 4.11 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D01B Antifungals for systemic use | 2020 | 0.32 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D03 Means for wounds & ulcers treatment | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D05A Antipsoriatics for topical use | 2020 | 0.18 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D05B Antipsoriatics for systemic use | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D06 Antibiotics.. for dermatological use | 2020 | 4.78 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D06A Antibiotics for topical use | 2020 | 4.69 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | D06B Chemotherapeutics for topical use | 2020 | 0.11 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | G02B Contraceptives for topical use | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | H02 Corticosteroids for systemic use | 2020 | 0.68 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J General antiinfectives for system.use | 2020 | 8.50 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J01 Antibacterials for systemic use | 2020 | 8.16 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J02 Antimycotics for systemic use | 2020 | 0.20 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J02A Antimycotics for systemic use | 2020 | 0.20 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J04A Drugs for treatment of tuberculosis | 2020 | 0.01 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J04B Drugs for treatment of lepra | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | J05 Antivirals for systemic use | 2020 | 0.06 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | M05 Drugs for treatment of bone diseases | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | M09 Oth.drugs for musculo-skelet.disord. | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | R03 Drugs for obstruct. airway diseases | 2020 | 8.06 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | R03C Adrenergics for systemic use | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | R06 Antihistamines for systemic use | 2020 | 9.18 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | R06A Antihistamines for systemic use | 2020 | 9.18 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | V06A Obesity treatment diet formulations | 2020 | 0.00 |
Total male and female | 0 to 14 years | (former) Net Antilles, Aruba | V06C Infant formulas | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A02 Drugs for acid related disorders | 2020 | 1.03 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A02B Drugs for peptic ulcer and gord | 2020 | 1.03 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A02X Oth. drugs for acid related disord. | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A03 Drugs for funct.gastrointest.disord. | 2020 | 1.40 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A03A Drugs for functional bowel disord. | 2020 | 0.35 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | A14 Anabolic agents for systemic use | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | B Blood and blood forming organs | 2020 | 2.86 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D01 Antifungals for dermatological use | 2020 | 4.15 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D01A Antifungals for topical use | 2020 | 3.91 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D01B Antifungals for systemic use | 2020 | 0.35 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D03 Means for wounds & ulcers treatment | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D05A Antipsoriatics for topical use | 2020 | 0.11 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D05B Antipsoriatics for systemic use | 2020 | 0.01 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D06 Antibiotics.. for dermatological use | 2020 | 2.91 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D06A Antibiotics for topical use | 2020 | 2.04 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | D06B Chemotherapeutics for topical use | 2020 | 0.92 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | G02B Contraceptives for topical use | 2020 | 0.58 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | H02 Corticosteroids for systemic use | 2020 | 0.87 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J General antiinfectives for system.use | 2020 | 14.91 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J01 Antibacterials for systemic use | 2020 | 13.58 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J02 Antimycotics for systemic use | 2020 | 1.09 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J02A Antimycotics for systemic use | 2020 | 1.09 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J04A Drugs for treatment of tuberculosis | 2020 | 0.04 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J04B Drugs for treatment of lepra | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | J05 Antivirals for systemic use | 2020 | 0.54 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | M05 Drugs for treatment of bone diseases | 2020 | 0.03 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | M09 Oth.drugs for musculo-skelet.disord. | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | R03 Drugs for obstruct. airway diseases | 2020 | 4.99 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | R03C Adrenergics for systemic use | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | R06 Antihistamines for systemic use | 2020 | 8.40 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | R06A Antihistamines for systemic use | 2020 | 8.40 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | V06A Obesity treatment diet formulations | 2020 | 0.00 |
Total male and female | 15 to 24 years | (former) Net Antilles, Aruba | V06C Infant formulas | 2020 | 0.00 |
Total male and female | 25 to 34 years | (former) Net Antilles, Aruba | A02 Drugs for acid related disorders | 2020 | 2.62 |
Source: CBS. |
Table explanation
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.
Data are broken down by medicine group, background, generation, age and sex.
Data available from 2006 to 2020.
Status of the figures:
All figures are definite.
Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.
When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.